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The ongoing 1000 brains study (1000BRAINS) is an epidemiological and neuroscientific
investigation of structural and functional variability in the human brain during aging. The
two recruitment sources are the 10-year follow-up cohort of the German Heinz Nixdorf
Recall (HNR) Study, and the HNRMultiGeneration Study cohort, which comprises spouses
and offspring of HNR subjects. The HNR is a longitudinal epidemiological investigation
of cardiovascular risk factors, with a comprehensive collection of clinical, laboratory,
socioeconomic, and environmental data from population-based subjects aged 45–75 years
on inclusion. HNR subjects underwent detailed assessments in 2000, 2006, and 2011,
and completed annual postal questionnaires on health status. 1000BRAINS accesses
these HNR data and applies a separate protocol comprising: neuropsychological tests of
attention, memory, executive functions and language; examination of motor skills; ratings
of personality, life quality, mood and daily activities; analysis of laboratory and genetic data;
and state-of-the-art magnetic resonance imaging (MRI, 3 Tesla) of the brain. The latter
includes (i) 3D-T1- and 3D-T2-weighted scans for structural analyses and myelin mapping;
(ii) three diffusion imaging sequences optimized for diffusion tensor imaging, high-angular
resolution diffusion imaging for detailed fiber tracking and for diffusion kurtosis imaging;
(iii) resting-state and task-based functional MRI; and (iv) fluid-attenuated inversion recovery
and MR angiography for the detection of vascular lesions and the mapping of white
matter lesions. The unique design of 1000BRAINS allows: (i) comprehensive investigation
of various influences including genetics, environment and health status on variability in
brain structure and function during aging; and (ii) identification of the impact of selected
influencing factors on specific cognitive subsystems and their anatomical correlates.
Keywords: cohort, connectivity, Heinz Nixdorf Recall Study, resting-state, imaging genetics, variability, aging,
elderly
INTRODUCTION
The process of aging varies widely between individuals, particu-
larly in relation to cognitive abilities, motor skills, and changes in
brain structure and function (for review e.g., Stern, 2009, 2012;
Bartrés-Faz and Arenaza-Urquijo, 2011). The aging spectrum
ranges between accelerated aging and the preservation of high
levels of physical fitness and mental agility into old age (Tucker
and Stern, 2011). Appraisal of the implications of aging also varies
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widely between individuals (for review e.g., Jeste et al., 2010), and
the concept of “successful aging” has been the focus of extensive
research (for review e.g., Vaillant and Mukamal, 2001; Depp and
Jeste, 2006).
Studies comparing elderly and young subjects have gener-
ated evidence for correlations between changes in physical and
mental performance and changes in brain morphology and activ-
ity across various cognitive domains (for review e.g., Cabeza,
2002; Grady, 2008; Spreng et al., 2010; Eyler et al., 2011; Turner
and Spreng, 2012). Changes in motor performance, attention,
(working) memory, executive control, and processing speed are
of particular interest, since deterioration in these domains has a
detrimental impact on the activities of daily living (for review e.g.,
Park and Reuter-Lorenz, 2009; Reuter-Lorenz and Park, 2010). In
addition to a decline in the integrity of the musculoskeletal sys-
tem, central motor control and execution are adversely affected
by aging, leading to a decrease in the capacity to plan and coordi-
nate complex movements (for review e.g., Krampe, 2002; Seidler
et al., 2010). This in turn increases the risk of falls (for review e.g.,
Bloem et al., 2003).
At the time of writing, the factors which influence cognitive
reserve capacity remain largely unknown (Ward, 2006). Previous
studies have suggested the existence of compensatorymechanisms
that maintain stable performance over time, e.g., by increasing
functional connectivity between brain areas. In contrast, other
studies of aging reported only limited or no compensatory effects
at all (for review e.g., Raz and Rodrigue, 2006; Goh and Park,
2009; Steffener and Stern, 2012). Few data are available concern-
ing differences in the compensatory capacity of the human brain.
However, this capacity is likely to be influenced by a range of
currently unknown factors (Tucker and Stern, 2011). Delineating
structural and functional brain plasticity and adaptability during
aging in elderly is rendered even more challenging. Structural and
functional brain changes have been found throughout the life-
span, from early to late adulthood (e.g., Pieperhoff et al., 2008;
Mowinckel et al., 2012). For this reason, identification of poten-
tial influencing factors and their interactions with brain function
or behavior in elderly is insufficient. Instead, research must also
determine why the presence or absence of a given factor may
result in completely different brain phenotypes in different sub-
jects. At present, the respective interplay between genetic and
environmental factors remains unclear.
Available research therefore indicates the existence of consider-
able interindividual variability in aging as a result of an interplay
between numerous external (e.g., environmental, psychoscocial,
socioeconomic) and internal (e.g., genetic, physiological) factors.
Characterization of how the range of observable phenotypes in
the aging brain is influenced by or relates to these factors and
any interactions of them may therefore facilitate disentanglement
of the underlying processes of aging. To represent variability in
the aging process of the human brain, investigation of a large
cohort of elderly subjects from the general population is required.
Furthermore, the research approach must involve comprehen-
sive analysis of structural and functional brain phenotypes and
related motor and cognitive performance, as well the investiga-
tion of a wide range of factors with a potential role in the observed
behavioral, structural, and functional variability.
The ongoing 1000BRAINS study was designed to address these
challenges. The aims of 1000BRAINS are to: (i) identify age-
dependent changes in the elderly human brain; (ii) characterize
the phenotypical variability observed during brain aging; and
(iii) investigate the causes of intraindividual variability in the
process of aging. The 1000BRAINS cohort is being drawn from
two sources: (i) the longitudinal population-based GermanHeinz
Nixdorf Recall (HNR) Study (Schmermund et al., 2002; Erbel
et al., 2012), whose dataset represents a valuable resource for
aging research; and (ii) the HNR MultiGenerationStudy, which
is comprised of the spouses and offspring of HNR subjects. In
addition to use of the HNR data, 1000BRAINS involves state-of-
the-art neuroimaging methods andmolecular genetic techniques.
Neuroimaging represents a powerful tool for detecting even sub-
tle changes in brain morphology and function during brain aging
in elderly subjects, while increasing understanding of the human
genome and the use of innovative molecular genetic techniques
may provide insights into the genetic processes which underlie
variation in age-related brain phenotypes.
The aim of the present report is to describe the cohort, the
protocol, and the magnetic resonance imaging (MRI) methods of
the 1000BRAINS study.
STUDY DESIGN
1000BRAINS is a cohort study. A total of 1000 subjects will be
recruited from two existing cohorts and assessed in order to char-
acterize interindividual variability in brain aging. A sample size of
n = 1000 was selected as determination of correlations between
variability in brain structure and function with increasing age and
environmental and genetic risk factors requires a large cohort.
This sample size is comparable to those of previous large-scale
neuroimaging studies in Europe and the US (Mueller et al., 2005;
Ikram et al., 2012; Van Essen et al., 2012), which achieved a uni-
form distribution of subjects in different age groups (Button et al.,
2013). An adequate sample size is also required to detect genetic
influences with small effect sizes in polygenic phenotypes (Stein
et al., 2012). An advantage of 1000BRAINS is that for all levels
of data the applied methods and testing procedures are consistent
across all subjects. This optimizes their reliability and generates
homogeneous data in a large sample of subjects.
RECRUITMENT SOURCES
The aim of the HNR study is to investigate correlations between
lifestyle-, social-, and environmental conditions and risk fac-
tors for (i) atherosclerosis (in particular coronary calcification);
and (ii) myocardial infarction (Recall: Risk factors evaluation of
coronary calcium and lifestyle). The baseline HNR cohort was
recruited from a sample that had been drawn at random from the
citizen registries of the cities of Essen, Bochum, and Mühlheim.
These cities are located in the Ruhr area, a metropolitan region
with a population of>11million. Recruitment for the HNR study
commenced in 2000 with the inclusion of 4814 subjects aged
45–75 years (50.2% female; baseline response 56%). The 5 year
follow-up assessments commenced in 2006 (response: 90%). The
10 year follow-up assessments commenced in June 2011 and are
ongoing at the time of writing. The extensive HNR study protocol
comprises standardized physical examinations, questionnaires,
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and interviews at baseline and at 5- and 10-year follow-up. In
addition, subjects have completed annual postal questionnaires
on health status.
Subjects attending the 10-year HNR follow-up assessment
(estimated total number: 3500 subjects) are asked to participate
in 1000BRAINS. To date, 71% of HNR subjects have been willing
to participate in 1000BRAINS, while a further 7%were undecided
at the time of first contact. At the HNR study center in Essen,
unwillingness to participate in 1000BRAINS has been attributed
to: (i) unwillingness to undergo further extensive examinations,
which involve a journey of 100–120 km (90–120min driving time,
depending on place of residence and traffic) to the 1000BRAINS
research site at the Research Centre Jülich; and (ii) the presence
of debilitating major illnesses such as cancer or cardiorespi-
ratory insufficiency. Subjects who are willing to participate in
1000BRAINS are screened for eligibility according to specified
exclusion criteria (see section Study Protocol). To date, 23%
of all HNR 10-year follow up subjects have been included in
1000BRAINS. The first 1000BRAINS assessments were completed
in September 2011 (Figure 1).
The HNR MultiGeneration Study commenced in January
2013. In this study, the spouses and offspring of the baseline HNR
subjects are being recruited in order to investigate cardiovascu-
lar risk factor burden and the related incidence of cardiovascular
disease within families. Approximately 5500 individuals are eli-
gible for this sample. A detailed description of this study will
be provided elsewhere. 1000BRAINS commenced its recruitment
of HNR MultiGeneration Study subjects in April 2013. Inclusion
of these subjects in 1000BRAINS in particular enables investiga-
tion of both: (i) younger subjects (i.e., <55 years); and (ii) the
influence of inherited genetic factors and their interaction with
environmental factors on brain aging phenotypes.
As of December 31st 2013, a total of 653 subjects from these
two HNR cohorts had been examined in accordance with the
1000BRAINS study protocol.
STUDY PROTOCOL
To enable comprehensive investigation of the aging of the human
brain and its interindividual variability in aging, 1000BRAINS
applies state-of-the-art neuroscientific methods and techniques.
These include: (i) a detailed MRI protocol for studying the struc-
ture and function of the aging brain; and (ii) neuropsychological
tests of a wide range of cognitive functions and aspects of motor
performance. Psychological variables, such as personality traits
FIGURE 1 | Timeline of the 1000BRAINS study which commenced in
September 2011. The figure is subdivided into the two recruitment
sources, i.e., the cohorts of the Heinz Nixdorf Recall Study and the Heinz
Nixdorf MultiGeneration study.
and the presence or absence of a subjective sense of well-being, are
measured using standardized questionnaires. Laboratory, genetic,
epigenetic, and expression analyses are performed to identify
whether specific blood metabolites, genetic polymorphisms, epi-
genetic signatures or expression profiles influence brain aging
phenotypes. Details of each aspect of the protocol are provided
below. The study protocol was approved by the ethics committee
of the University of Duisburg-Essen. The study procedures com-
ply with the Declaration of Helsinki. Strict internal and external




Study exclusion is conditional on eligibility for MR measure-
ments. The MR exclusion criteria used in 1000BRAINS are con-
sistent with standard ethical and MR safety guidelines for the MR
examination of healthy subjects for an exclusively scientific pur-
pose. HNR subjects are excluded from 1000BRAINS if any of the
following are present: coronary artery stents; cardiac pacemak-
ers; or surgical implants or prostheses in the trunk or head. This
is a necessary precaution, since during the scanning procedure,
the brain, trunk, and head are exposed to a strong static mag-
netic field, pulsed magnetic field gradients, and radiofrequency
fields. Further exclusion criteria are: claustrophobia; a history of
neurosurgery; and the presence of tattoos or permanent make-up
on the head. Dental implants and bridges are relative contraindi-
cations. In such cases, scanning is discontinued if the respective
object produces artifacts in the brain images during the localizer
sequence stage.
Potential 1000BRAINS participants are informed of the aims
and procedures of the study at the HNR study center in
Essen by trained study personnel. During this discussion, they
are also screened for MR contraindications using a standard-
ized interview. Willing and eligible subjects are then asked to
sign the informed consent form, and an appointment for the
1000BRAINS examination in Jülich is arranged. An uncertain sur-
gical history is clarified by requesting a report from the hospital
at which surgery was performed. The report is then evaluated by
an experienced physician and anMR physicist responsible for MR
safety at the Research Centre Jülich. These experts then make the
final decision regarding eligibility for study participation. This
approach enables avoidance of the general exclusion of subjects
who have undergone surgery and thus maximizes recruitment.
Quality assurance
All examinations and testing procedures are conducted in accor-
dance with predefined guidelines, as detailed in the respective
standard operating procedures. MRI is performed by trained
technical personnel. Neuropsychological and motor testing are
performed by raters (experienced study nurse as well as assistants
at bachelors and masters level). The raters are trained by an expe-
rienced neuropsychologist for the neuropsychological testing and
by an experienced neurologist for the motor testing and have then
undergone a period of supervision before being allowed to assess
subjects independently. All raters are continuously supervised to
assure constant quality of the testing. Quality control is further
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assured by the video taping of all tests for evaluation of the neu-
ropsychological testing by an experienced neuropsychologist and
of the motor testing by an experienced neurologist.
The MR data of all subjects are reviewed by an experienced
radiologist in order to: detect pathological findings, in which case
the subject is excluded from further analysis; and (ii) report on
any incidental findings requiring medical attention (see below).
An established data base system is used for data storage and
management (see below). Double data entry is performed to
optimize quality control.
Incidental findings
Since the MRI data of the 1000BRAINS subjects are reviewed
by an experienced radiologist, incidental findings may arise.
During the informed consent procedure and prior to inclusion, all
potential 1000BRAINS subjects must agree to be informed about
any incidental finding requiring medical attention. Subjects who
refuse this will be excluded from the study. This strategy is in
accordance with current guidelines (e.g., http://www.bioethics.
gov), and with standard procedures implemented in on-going
brain imaging studies (e.g., Study of Health in Pomerania (SHIP),
Hegenscheid et al., 2009, 2013). If the radiologist reports an
incidental finding, the case is discussed by the members of an
internal 1000BRAINS disease advisory board, which is comprised
of physicians and epidemiologists. The board decides whether
the subject should be informed. If indicated, the respective sub-
ject is then informed of the finding by a study physician, and
requested to consult their primary care physician for further eval-
uation and management. This procedure is regularly discussed
with neuroethicists.
Conditions requiring urgent medical evaluation include brain
tumors, arteriovenous malformations, aneurysms, hemorrhages,
inflammation, and acute stroke. Conditions warranting routine
medical referral include post stroke status or mucosal thickening
within the sinus and the mastoid cells. Age-related brain changes
may also be detected. These include white matter lesions, which
are a frequent radiological finding. In accordance with previous
studies (e.g., SHIP, Hegenscheid et al., 2009), such age-related
findings will not be reported to the subject.
MEASUREMENTS AND TESTING
Magnetic Resonance Imaging (MRI)
MRI is carried out on a 3 Tesla MR scanner (Tim-TRIO, Siemens
Medical Systems, Erlangen, Germany). A range of sequences have
been chosen to maximize insight into the structure and function
of the brain in a large number of subjects within a reasonable
time-frame (Table 1, Figure 2).
Structural scans include an anatomical 3D T1-weighted
MPRAGE sequence, a 3D T2-weighted SPACE sequence, a clin-
ical T2-weighted FLAIR sequence, MR-angiography of the basal
brain arteries without contrast agents using a Time of Flight
(ToF) sequence, and 3 different diffusion-weighted sequences
(30/60/120 diffusion directions). The latter are optimized for
the following processing strategies: (i) diffusion tensor imaging
(DTI), with emphasis on the analysis of fractional anisotropy as
a measure of white matter integrity; (ii) high angular resolution
diffusion imaging (HARDI) data to allow tractography-based
reconstructions of white matter fiber paths (Figure 2); and (iii)
diffusion kurtosis imaging as a measure of white matter integrity
under non-Gaussian assumptions of water diffusion in the brain.
Functional scans include a resting-state scan of 11min dura-
tion (eyes closed, light switched off, instruction: let the mind
wander without thinking of anything in particular), and func-
tional imaging paradigms for a range of functional systems.
The latter include action processing, working memory, stimulus-
response mapping, and quantifier processing. Using optimized
sequence parameters and parallel imaging, the total scanning
time is approximately 75–90min, depending on the functional
imaging paradigm.
An example of variability in a specific brain phenotype is
depicted in Figure 3A. Here, intersubject variability in the com-
position of the resting-state networks is demonstrated in terms
of eigenvariates. Both the posterior default mode and the frontal
executive network (as described by Smith et al., 2009) are present
Table 1 | Overview over the MRI sequences used in 1000BRAINS with relevant sequence parameters.
Name Sequence parameters
T1 (3D-MPRAGE) 176 slices, TR = 2.25 s, TE = 3.03ms, TI = 900ms, FoV = 256 × 256mm2, flip angle = 9◦, voxel resolution = 1 × 1 × 1mm3
T2 (3D-SPACE) 176 slices, TR = 3.2 s, TE = 417ms, FoV = 256 × 256mm2, voxel resolution = 1 × 1 × 1mm3
DTI (30 directions) EPI, TR = 7.8 s, TE = 83ms, 4 b0-images (interleaved), 30 images with b = 1000 s/mm2, voxel resolution = 2 × 2 × 2mm3
DTI (60 directions,
HARDI subset)
EPI, TR = 6.3 s, TE = 81ms, 7 b0-images (interleaved), 60 images with b = 1000 s/mm2, voxel resolution = 2.4 × 2.4 × 2.4mm3
HARDI (120
directions)
EPI, TR = 8 s, TE = 112ms, 13 b0-images (interleaved), 120 images with b = 2700 s/mm2, voxel resolution = 2.4 × 2.4 × 2.4mm3
Functional and
resting-state MRI
EPI, 36 slices, TR = 2.2 s, TE = 30ms, FoV = 200 × 200mm2, flip angle = 90◦, voxel resolution = 3.1 × 3.1 × 3.1mm3
T2 (FLAIR) 25 slices, TR = 9 s, TE = 100ms, FoV = 220 × 220mm2, flip angle = 150◦, voxel resolution = 0.9 × 0.9 × 4mm3
Angiography (ToF) 40 slices, TR = 22ms, TE = 3.86ms, voxel resolution = 0.7 × 0.5 × 0.7mm3
DTI, diffusion tensor imaging; EPI, gradient-echo echoplanar imaging; FLAIR, fluid-attenuated inversion recovery; FoV, field of view; HARDI, high angular resolution
diffusion imaging; MPRAGE, magnetization prepared rapid acquisition gradient echo; SPACE, sampling perfection with application optimized contrasts using different
flip angle evolution; TE, echo time; TI, inversion time; ToF, time of flight; TR, repetition time. T1, T2, weighting of the applied MRI sequence.
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FIGURE 2 | Images illustrating the different modalities of magnetic
resonance imaging data acquired in 1000BRAINS (cf. Table 1). (A)
T1-weighted; (B) T2-weighted; (C) fluid attenuated inversion recovery
(FLAIR); (D) axial maximum intensity projection (MIP) of time-of-flight
angiography; (E) high angular resolution diffusion imaging (HARDI, one out
of 120 diffusion weighted images); (F) functional and resting-state
echo-planar image (EPI). (G) Additionally, exemplary reconstruction of
whole brain fiber architecture from HARDI data [as depicted in (E)], using
TrackVis software (http://www.trackvis.org), from the lateral (left) and
anterior (right) views. Inlays show enlargements of the fiber architecture
within the inferior parietal cortex (top) and the pons and brainstem (bottom).
Color coding of fiber directions in accordance with common conventions
(blue: top—bottom; red: left—right; green: rostral—caudal).
in all subjects. However, wide variation is observed between sub-
jects in terms of the extent and involvement of the posterior
cingulate and angular gyrus or medial frontal areas respectively,
and thus the functional connectivity within these networks. The
following text describes variables of interest in 1000BRAINS,
i.e., variables that might explain some degree of the observed
variability in brain phenotype.
Neuropsychological assessment
Performance testing. The neuropsychological performance tests
applied in 1000BRAINS address a wide range of cognitive func-
tions. These tests enable identification of cognitive functions
that are differentially affected by aging, and assessment of the
respective consequences on brain imaging parameters. The result-
ing neuropsychological profiles allow comparison of intra- and
interindividual strengths and weaknesses, particularly in elderly
subjects. Specific functional tests include assessment of perfor-
mance in the domains of attention, memory, language skills, and
executive functions. The presence of early signs of dementia is
assessed using DemTect (Kalbe et al., 2004). This screening tool
assesses verbal and working memory and word fluency perfor-
mance as well as intellectual flexibility, and has a high sensitivity
for the detection of early dementia and mild cognitive impair-
ment. Total testing time is approximately 75–105min, depending
on subject performance. Table 2 provides an overview of all
cognitive tests administered in 1000BRAINS.
Some cognitive tests are designed specifically for the testing of
older subjects, i.e., 55 years and above, while others are designed
to test subjects aged 18–55 years (cf. Table 2). This allows appro-
priate testing of specific cognitive functions in both elderly and
younger subjects (i.e., those from the MultiGeneration Study).
Figure 3B illustrates the age distributions of the raw scores
of two neuropsychological variables in the currently avail-
able 1000BRAINS dataset. As shown by these scatter plots,
there is marked interindividual variability in these perfor-
mance measures, reflecting the underlying heterogeneity of this
population-based sample. Moreover, age effects seem to be
present, in particular in the performance of the Color Word
Interference Task (with older subjects taking longer to respond).
Importantly, both the examplary neuroimaging and neuropsy-
chological data illustrate a low number of outliers, indicating the
successful implementation of our standardized approach.
Self-report and observer-based ratings. An important aspect of
the process of aging is the subjective appraisal of aging and the
importance of cognitive impairment in terms of well-being and
quality of life (Reid and MacLullich, 2006; Jessen et al., 2010;
Jeste et al., 2010). These factors are measured in 1000BRAINS
using established psychometric questionnaires. These data will be
analyzed within the context of the neuroscientific and neuropsy-
chological data. Complementary analyses will focus on the nor-
mative aspects and ethical implications of the distinction between
normal and pathological aging, and the normative and ethical
implications of suspected or established dementia in terms of the
affected person’s standing within society (Sturma, 2011). A neces-
sary condition for answering the question how mental and phys-
ical processes of normal aging differ from pathological changes
is to establish criteria for the conception of “normality.” This
will make any assumptions on this concept transparent and will
render them open for argumentation and justification. It is of par-
ticular interest to clarify, whichmental and behavioral expressions
in early stages of dementia should still fall within the supposed
range of normality. This particularly necessitates an understand-
ing of how a person subjectively experiences her cognitive decline
and the associated altered reactions from her social environment.
Data concerning personality, quality of life, daily activities,
behavioral changes, psychiatric symptoms, handedness, and lan-
guage skills are also obtained within 1000BRAINS. With the
consent of the subject, ratings concerning changes in behavior
are also obtained from family members. An overview of all self-
rating and observer-based questionnaires used in 1000BRAINS is
provided in Table 3.
Motor assessment
Performance testing. Motor performance is assessed using tests
that evaluate motor functions that decline in old age. These
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FIGURE 3 | Exemplary depictions of interindividual variability in
phenotypes assessed in 1000BRAINS. (A) Composition of resting-state
networks and their variability with age, as expressed via the individual
eigenvariates (ICA decomposition using MELODIC; Beckmann and Smith,
2004) within FSL (http://www.fmrib.ox.ac.uk/fsl), displayed for the posterior
part of the default mode network and the frontal executive network. (B)
Distribution of performance in verbal fluency (measured via the
Regensburger Wortflüssigkeitstest, see Table 2) and susceptibility to
interference (measured via the Farb-Wort-Interferenztest according to Stroop,
see Table 2). Each blue dot indicates the resting-state network eigenvariate
(A) and the raw test score as achieved in the respective neuropsychological
test (B) for a given subject. Outliers are marked as red dots.
include uni- and bimanual fine- and gross motor skills for
proximal and distal upper limb function, as well as motor
sequence learning. Lower limb and gait performance is assessed
using various tests of gait. These account for dual task
performance by requiring a combination of motor and/or cog-
nitive task performance while walking. Stability of stance and
balancing capabilities are assessed on an oscillatory platform,
in a test which requires the subject to counterbalance sudden
platform displacement. An overview of all 1000BRAINS motor
performance tests is provided in Table 4.
Self-report and observer-based ratings. Gait and stance capabili-
ties are also evaluated using observer-rated tests. For the detection
of subclinical Parkinsonism, part III of the Unified Parkinson
Disease Rating Scale from routine clinical practice is adminis-
tered (Martínez-Martín et al., 1994). In addition, subjects are
asked to complete a self-report questionnaire concerning self-
confidence in maintaining balance in a variety of daily activ-
ities. An overview of the scores and ratings is provided in
Table 4.
Laboratory, genetic, epigenetic, and expression data
For each HNR and HNR-MultiGeneration subject, blood sam-
ples are drawn at the HNR study appointment in Essen. Within
1000BRAINS, measures of interest are those that are likely to
influence the structure and function of the aging brain. These
include hormones, metals, vitamins, lipids, dietary minerals as
well as cytokines (Moffat, 2005; Brewer, 2012; Joshi and Praticò,
2012; Lachner et al., 2012; Maggio et al., 2012). Furthermore, cel-
lular ormolecularmarkers of aging will be of interest (Lopéz-Otín
et al., 2013), particularly if the situation in the peripheral blood
reflects the situation in the brain.
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Table 2 | Neuropsychological performance tests as administered in 1000BRAINS.
Test (References) Functions Description
Trail making test A and B (taken from
CERAD-Plus) (Morris et al., 1989)
A: Visual attention, processing speed
B: Concept shifting
A: Connecting randomly arranged digits in an
ascending order by drawing lines




Selective attention Cancel a target figure out of similar distractor figures
D2-R** (Brickenkamp et al., 2010) Selective attention Cancel a target sign out of similar distractor signs
Verbaler Gedächtnistest (Lux et al., 2012) Verbal episodic memory Learning of a 15 words list in 5 trials, with free, cued
direct, and delayed recall
Benton-Test (Benton et al., 2009) Visual memory
Figural memory
Free recall of 20 figures
Block-Tapping-Test (Schelling, 1997) Visual spatial working memory Repeating a by trial increasing sequence of blocks on a
board of 9 blocks, in equal and reverse order
Visual pattern (Jülich version) (similar to: Della
Sala et al., 1997)
Visual working memory Memorizing a matrix pattern of black and white squares
in grids of increasing complexity
Fünf-Punkte-Test (Jülich version) (similar to:
Regard et al., 1982)
Figural fluency Drawing different designs by connecting 5 dots with
lines
Subtest 3 (from Leistungsprüfsystem 50+)
(Sturm et al., 1993)
Problem solving Identifying (ir)regularity in a row of geometric figures
Zahlennachsprechen (from Nürnberger
Alters-Inventar) (Oswald and Fleischmann, 1997)
Verbal working memory Repeating a by trial increasing sequence of spoken
numbers in equal and reverse order
Regensburger Wortflüssigkeitstest
(Aschenbrenner et al., 2000)
Semantic/Phonemic verbal fluency Producing words beginning with a given letter(s) or
words from specific categories
Boston Naming Test (from CERAD; short form)
(Morris et al., 1989)
Word retrieval
Naming
Naming ink drawings of objects with increasing
difficulty
Farb-Wort-Interferenztest (Jülich version) (similar




Reading words with color meaning; naming the color of
colored boxes; naming the color of words with color
meaning, printed in a different color
Wortschatztest (Schmidt and Metzler, 1992) Vocabulary Identifying real words within a row of 5 pseudo-words




Tests are listed in the order in which they are performed. CERAD, Consortium to Establish a Registry for Alzheimer’s Disease; *only used in subject older than 55
years of age, **only used in subjects younger than 55 years of age.
For the genetic and epigenetic analyses, EDTA-anticoagulated
blood samples are stored separately as aliquots at −80◦C. In
a first step, genetic analyses within 1000BRAINS will focus on
the identification of common genetic factors with an influ-
ence on brain aging. This refers in particular to the most
abundant form of variation in the human genome, i.e., sin-
gle nucleotide polymorphisms (SNPs). A systematic genome-
wide search for SNPs with an influence on brain aging will be
performed (genome-wide association study). This will involve
microarrays that enable the parallel genotyping of millions of
SNPs. Previous research has identified a number of SNPs with a
structural or functional influence on brain phenotypes (Esslinger
et al., 2009; Erk et al., 2010; Bis et al., 2012; Stein et al., 2012).
However, most studies have focused on the effects of disease-
associated genetic variants (for review: Meyer-Lindenberg and
Weinberger, 2006; Meyer-Lindenberg and Zink, 2007; Meyer-
Lindenberg, 2010), and scant data are available concerning
genetic factors with an influence on variability in brain pheno-
types. Genotyping is performed at the Life & Brain Center of
the University of Bonn (Figure 4), using Illumina’s microarrays
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Table 3 | Neuropsychological self- and observer-based rating scales as used in 1000BRAINS.
Scale (Reference) Topic Function/Dimension
SF-36 Fragebogen zum Gesundheitszustand (Bullinger and
Kirchberger, 1998)
Quality of life in relation
to health
Self-report assessment of quality of life in relation to health
and any kind of illness. Dimensions covered are: vitality,
physical pain and functionality, physical and emotional role
function, social functionality, and mental well-being
Nürnberger Alters-Alltagsaktivitäten-Skala* (from
Nürnberger Alters-Inventar) (Oswald and Fleischmann,
1997)
Daily activities in elderly Rating of current instrumental and social abilities which
allows estimating limitations in daily activities as
experienced by the subjects
Nürnberger Lebensqualitäts-Fragebogen (from Nürnberger
Alters Inventar) (Oswald and Fleischmann, 1997)
Quality of life in general Assessment of general quality of life in elderly with
dimensions contentedness, well-being, partnership,
physical symptoms, and work performance
Beck-Depression-Inventory II (Hautzinger et al., 2006) Indicators of depression Self-report inventory assessing current symptoms of
depression and their severity, covering affective, and
somatic symptoms
Jülich Psychiatric Screening Questionnaire (JPS) Axis I and II Disorders
(DSM-IV)
Questionnaire on the psychological status in terms of major
mental and personality disorders
Edinburgh Handedness Inventory (Oldfield, 1971) Handedness Preference in using right or left hand, eye and foot
Freiburger Persönlichkeitsinventar (FPI-R) (Fahrenberg
et al., 2010)
Personality Self-report instrument to assess personality traits on 12
subscales: life satisfaction, social orientation, performance
orientation, shyness, irritability, aggression, stress, physical
complaints, health concerns, openness; and 2 secondary
factors (cf. Eysenck): extraversion, emotionality
(neuroticism)
Jülicher Inventar zu frontalem Verhalten (modified from




Possible behavioral changes related to a decrease of frontal
brain tissue are investigated
Jülicher Fragebogen zur Ermittlung von Sprachkenntnissen
(modified from Language experience and proficiency
questionnaire) (similar to: Marian et al., 2007)
Language skills Assessment of language skills in mother tongue as well as
any foreign language(s)
Jülicher Kurzfragebogen zur aktuellen Beanspruchung
(modified from Kurzfragebogen zur aktuellen
Beanspruchung) (Müller and Basler, 1993)
Current stress level Questionnaire on the evaluation of the current stress level
before and after testing
Jülicher Fragebogen zu Subjektiven Kognitiven
Beeinträchtigungen I & II (JFSKB-I & JFSKB-II)
Subjective cognitive
impairment
Questionnaires for obtaining subjective impairment in
several areas of cognitive functioning (absolute and
comparative)
Jülicher Fragebogen zur Alzheimer Krankheit und Demenz Alzheimer’s disease and
dementia
Questionnaire on the evaluation of and coping with
Alzheimer’s disease and dementia
*Only used in subject older than 55 years of age.
of the Omni series, which encompasses up to 1.92 million SNPs
per individual. Use of genome-wide SNP data also will allow the
application of methods which attempt to account for the pro-
nounced polygenicity of many complex phenotypes. Polygenic
score analyses evaluate whether common variants have an impor-
tant role on normal aging en masse through direct testing of
the classic theory of polygenic inheritance (e.g., International
Schizophrenia Consortium, 2009). Another widely used approach
that will be applied in 1000BRAINS is pathway analysis. The
aim of this approach is to identify whether extended lists of
SNPs with association signals are enriched in defined biological
pathways.
Besides these systematic, genome-wide searches for genetic
factors with an influence on phenotypes of interest within
1000BRAINS, analyses of individual candidate genes or candidate
gene systems will be performed. Of particular interest is the ques-
tion of the extent to which common genetic risk factors in genes
previously implicated in brain disorders, e.g., neurodegenerative
or neuropsychiatric disorders, influence the observed variability
in brain aging.
Frontiers in Aging Neuroscience www.frontiersin.org July 2014 | Volume 6 | Article 149 | 8
Caspers et al. Rationale and design of 1000BRAINS
Table 4 | Motor assessment as administered in 1000BRAINS.
Test (Reference) Functions/Parameters Description
PERFORMANCE TESTS
Finger Pointing test (adopted from
CAPSIT-PD) (Defer et al., 1999)
Fine motor coordination (speed and
accuracy)
Moving index finger 10 times between two target buttons,
which are 30 cm apart from each other, at maximum pace
Finger Tapping test (adopted from
Halstead, 1947)
Manual dexterity, fine motor coordination
(rate, regularity)
Tapping index fingers
1. With right/left at internal pace
2. With right/left at maximum pace
3. Alternating between right and left index fingers with
increasing and decreasing pace
Motor Sequences test (adopted from
Luria, 1973)
(Uni- /Bimanual Motor Sequence Learning) Series of hand movements
1. Left/right hand: fist, edge, palm
2. Bimanual: alternating fist, palm
3. Bimanual: alternating dorso-ventral hand flaps with
elevated and flexed arms
Multiple Tasks Gait test (Jülich version)
(similar to: Haggard et al., 2000; Bloem
et al., 2001)




Walking for 25 m
1. Free at internal pace
2. With loaded tray (glass and cup (saucer) filled with water)
3. 2 + spatial imagination task
(determining whether position of hour and minute hands
are on the same or on different sides of the clock face, for
various given times)
4. 2 + verbal task
(deciding if given words contain letters A and R)
Posturomed Oscillatory Platform
(Posturomed®, HAIDER BIOSWING
Weiden, Germany) (Müller et al., 2004;
Boeer et al., 2010)




Two-legged stance counterbalancing of platform movement
following standardized sudden platform displacements
toward left, right, and rear
SELF- AND OBSERVER-BASED RATINGS
EPESE Score
(Guralnik et al., 1994)
Lower extremity function, predictor of
mortality estimation and nursing home
admission
Total score of tests of balance, time to walk 8 foot, and
time to rise from a chair 5 times
FTSS Score (Buatois et al., 2008) Postural stability, prediction of risk of falls Time to rise from a chair 5 times without arm/hand
assistance
(Semi-) Tandem Stance (from Berg
Balance Scale) (Berg et al., 1989)
Postural stability Both feet placed along a single straight line (toes touching
heel in tandem stance, not touching in semitandem stance)
UPDRS Part III (Martínez-Martín et al.,
1994)
Detection of (subclinical) Parkinson motor
symptoms
Motor examination with rating of gait, stance, and
hand/arm/leg movements
Activities-specific Balance Confidence
Scale (ABC) (Powell and Myers, 1995)
Balance self-confidence Subjective assessment of balance confidence in different
daily activities
CAPSIT-PD, Core Assessment Program for Surgical Interventional Therapies; EPESE, Established Populations for the Epidemiologic Study of the Elderly; FTSS, Five
Time Sit to Stand; UPDRS, Unified Parkinson Disease Rating Scale.
In addition, epigenetic studies focusing on DNA methylation
and studies of gene expression will be performed. Future use of
exome- or genome-wide sequencing might also be considered
within 1000BRAINS.
DATA STORAGE, MANAGEMENT, AND ACCESS
All data are stored in a pseudonymized manner in accor-
dance with current data safety and protection guidelines.
To optimize management of the extensive neuroimaging-,
neuropsychological-, and genetic data sets generated in
1000BRAINS, the LORIS (Longitudinal Online Research
and Imaging System) is being used. LORIS is a neuroinformatics
research database system developed by the Montreal Neurological
Institute at McGill University, Montreal, Canada (http://www.
loris.ca; Das et al., 2012). LORIS is based on a MySQL database
server and offers a web-based user interface, which renders it
particularly suitable for multi-center trials (e.g., NIHPD—US
study on normal child brain development, IBIS—US study
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FIGURE 4 | Management and organizational structure of the 1000BRAINS study.
on autism, GUSTO—large birth cohort of the University of
Singapore). To ensure compliance with Germany’s strict data
security and handling guidelines, LORIS has been installed on
a separate server at the Institute of Neuroscience and Medicine,
Research Centre Jülich, Germany, with no possibility of external
access. An important advantage of LORIS is its capability for the
automatized quality control of entered data. The double-data
entry option ensures that incorrect entries are detected.
Access to 1000BRAINS data by researchers will be granted
on the basis of the scientific value of the proposed research
project (Figure 4). A steering committee comprised of the prin-
cipal investigators of 1000BRAINS has been established. This
committee includes experts in neuroscience, epidemiology, and
genetics. The steering committee will decide upon the accep-
tance of research proposals using defined data usage guidelines.
Upon completion of the respective research project, the investi-
gators will be required to forward all results to the 1000BRAINS
group at the Research Centre Jülich, where they will be archived.
Proposals for collaborative projects should be directed to
k.amunts@fz-juelich.de or s.caspers@fz-juelich.de.
DISCUSSION
STUDY DESIGN: STRENGTHS AND LIMITATIONS
1000BRAINS has been designed to investigate variability in
human brain aging. This is facilitated by two key aspects of the
study: (i) use of the extensive dataset of the unique population-
based HNR Study, which has been obtained through the 10 year
longitudinal evaluation of cardiovascular, life style, and socioeco-
nomic factors; and (ii) investigation of a wide range of potential
influencing factors and their interactions, using a multi-modal
approach comprising neuroimaging, behavioral and cognitive
testing, genetics, and blood parameters. The interactions between
genetic and lifestyle factors can be regarded as being partic-
ularly relevant. It could be assumed that age-related changes
are amplified or counteracted by given lifestyle variables (Watt,
2014). The combination of the 1000BRAINS data with the sur-
veys on exercise, dietary habits, sleep, and social environment
of the subjects, which are available via the database of the
HNR Study (Schmermund et al., 2002), provides the oppor-
tunity to investigate into these interactions. This will broaden
the understanding of the role of genes and lifestyle on the
process of aging.
Age-related changes in brain structure and function might be
subtle. Large samples are therefore required to detect small, but
nonetheless relevant, effects. This is also the case for genetic influ-
ences. Recent studies on different brain phenotypes have reported
notable genetic effects, even for genetic factors with a low pene-
trance (Bis et al., 2012; Stein et al., 2012). In terms of variability in
human brain aging, each individual genetic factor might explain
only a small proportion of the striking variability observed in
aging brain phenotypes. To ensure adequate sample sizes, recent
investigations have pooled samples from a number of studies
(e.g., Stein et al., 2012). While this generates very large samples,
such efforts raise potential difficulties in terms of data heterogene-
ity. An advantage of 1000BRAINS is that its well-characterized
sample is being examined using the same equipment and research
instruments. Reducing technical and methodical variability is
a crucial prerequisite for the reliable investigation of biological
interindividual variability.
As in other in-vivo neuroimaging studies, analysis of the vari-
ability of structural, functional, and connectional phenotypes
of the aging brain within 1000BRAINS is limited to millime-
ter resolution. To integrate neuroanatomical information at the
microscopic level into the 1000BRAINS analyses, data from the
JuBrain Cytoarchitectonic Atlas (http://www.jubrain.fz-juelich.
de) will be included. This atlas classifies the cortex and the sub-
cortical structures on the basis of microstructural criteria. Precise
anatomical definition of structurally-functionally relevant sub-
units of the cortex offers several advantages. Firstly, it allows
anatomically and neurobiologically informed interpretation of
the neuroimaging data (Zilles and Amunts, 2010; Caspers et al.,
2013). Secondly, it increases the methodical homogeneity of the
data by defining these modules in a standardizedmanner. Thirdly,
it reduces technical variance. This in turn allows more specific
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characterization of factors which influence variability in human
brain aging.
ETHICAL CONSIDERATIONS
1000BRAINS has established a standardized procedure for the
detection and reporting of incidental findings. This combines
expert radiological review, discussion within an internal disease
advisory board, and the provision of regular advice by experts in
neuroethics. At the time of writing, the issue of incidental findings
is a matter of intense debate within the neuroimaging commu-
nity (Illes et al., 2004a; Booth et al., 2010; Lanzerath et al., 2013).
It is also an important issue for ethical review boards and for
the field of neuroethics in general (Illes et al., 2004b; Illes and
Chin, 2008; Wolf et al., 2008). Since incidental findings are preva-
lent in the general population (2–8%; Illes et al., 2004a; Vernooij
et al., 2007), they must be anticipated in a large-scale neuroimag-
ing project, particularly one involving the investigation of elderly
subjects using higher MR field strengths and higher resolution
of the structural sequences (Morris et al., 2009). The issue of
how to manage incidental findings within neuroimaging research
involves consideration of the subject’s right to self-determined
knowledge, a physician’s duty and professional ethical code with
respect to informing an individual of the presence of a potentially
serious condition and the offering of appropriate management,
and the interest of society and the national economy in avoid-
ing the cost of unnecessary clinical examinations. A recent report
concerning experience in the SHIP found that the majority of
subjects expressed a wish to be informed of any relevant finding
(Schmidt et al., 2013). The approach used within 1000BRAINS is
designed to take the competing interests of physicians, researchers
and participants into account. In doing so, 1000BRAINS adheres
to the current recommendations for the ethical management of
incidental and secondary findings of the Presidential Commission
for the Study of Bioethical Issues (http://www.bioethics.gov).
1000BRAINS also aims to elucidate the subject’s personal
experience of the aging process and how this correlates with
objective measures of aging, i.e., those related to variability in
brain structure and function and performance. The aging pro-
cess is also perceptible within society as a whole. Distinguishing
specific aspects of the aging process within individuals from
the overall, normative aspects of aging is therefore of inter-
est (McMullin, 2000), since this determines how the elderly are
perceived and accepted within society, and which ethical issues
should be considered, e.g., when working with individuals with
dementia (Sturma, 2011). 1000BRAINS approaches these ques-
tions by including self-reported appraisal of the aging process in
relation to performance, as well as life-style- and environmental
factors.
1000BRAINS IN RELATION TO OTHER EPIDEMIOLOGICAL COHORT AND
LARGE-SCALE IMAGING STUDIES
Over recent years, several large-scale neuroimaging projects have
been established for the investigation of diverse hypotheses. Most
have focused on studying changes in the brain in relation to
disease. The following discussion focuses on those aspects of
1000BRAINS that are novel in relation to other on-going neu-
roimaging projects.
The Rotterdam Study (Hofman et al., 1991) commenced in
1990 with the investigation of subjects aged 55 years and above.
In 2000 and 2006, the cohort was extended with the inclusion
of subjects aged 45 years and above. The main focus of the
Rotterdam study is the identification of causes of common dis-
eases in the elderly. In terms of neurology, the major foci of the
study are neurodegenerative and cerebrovascular diseases, differ-
ent types of dementia, Parkinson’s disease, and stroke (Hofman
et al., 2007, 2009, 2011). The relation between changes in brain
structure and function and relevant disease-related risk factors
is addressed using 1.5T MR imaging (de Groot et al., 2001;
Ikram et al., 2012). CASCADE (Cardiovascular Determinants
of Dementia; Launer et al., 2000) is a collaboration of various
established cohort studies. Here, short- and long-term cardiovas-
cular causes of dementia are assessed within the pooled dataset
of the included cohorts—with a focus on white matter lesions
and gray matter structure—using 1.0T MRI imaging. The ADNI
project (Alzheimer’s Disease Neuroimaging Initiative; Mueller
et al., 2005; Weiner et al., 2010, 2012) is a multi-center study
which aims to identify differences between healthy elderly sub-
jects, subjects with mild cognitive impairment, and patients with
Alzheimer’s disease. The major focus of the ADNI neuroimag-
ing protocol is brain structure, with investigation of structural
and functional connectivity. Being multi-centric, ADNI involves
different MR scanners from different vendors, all of which have
different field strengths (1.5 and 3T).
Whereas the aforementioned studies focus on neuroimaging,
the research aims of SHIP (Völzke et al., 2011) are very broad.
This study commenced in 1997 and covers a wide range of dis-
eases and related risk factors in subjects aged 20–70 years. The
neuroimaging aspects of the SHIP whole-body MR imaging pro-
tocol at 1.5T focus on structural sequences (Hegenscheid et al.,
2009).
The ongoing Human Connectome Project (HCP; Toga et al.,
2012; Van Essen et al., 2012) is a large scale neuroimaging project.
This aims to study structural and functional brain connectiv-
ity in sibships aged 20–35 years. The study protocol is focused
on advanced MR imaging at 3T and, in some cases, 7T, and
involves specially developed and optimized imaging sequences
for studying structural connectivity in relation to behavioral and
genetic data.
In contrast to these projects, 1000BRAINS focuses on aging
of the brain in elderly subjects. 1000BRAINS has been designed
to characterize interindividual variability in the aging process.
1000BRAINS is unique in combining neuroimaging for the
detailed assessment of brain structure, function and connectiv-
ity in the brain of older subjects with analysis of a variety of
environmental-, genetic-, life-style-, and behavioral factors. By
building upon the wealth of longitudinal data from the HNR
Study, the scope of 1000BRAINS is widened, thus allowing assess-
ment of the trajectories of potential influencing factors over a
period of 10 years.
CONCLUSIONS
1000BRAINS is based upon the population-based cohort of the
HNR study, which reached its 10-year follow-up stage in 2011
(Erbel et al., 2012). Use of the longitudinal HNR data and cohorts
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will allow identification of factors with a potential influence on
brain aging, e.g., cardiovascular- and life style factors. The system-
atic assessment of variability in brain structure and function in
the general population, with a major focus on the brain of elderly
subjects, will provide a neuroscientific basis for understanding
alterations in the diseased brain across a spectrum that comprises
normal variability, disturbed functioning, and manifest disease.
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